Compositions enriched in neoplastic stem cells and methods comprising same
A technology for stem cells and compositions, applied to compositions rich in neoplastic stem cells and fields containing the same, can solve problems such as troubles, damage to cell viability, inability to detect pure cell populations, and the like
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0137] Frequency of OCT4-expressing cells in tumors
[0138] To better investigate the frequency of OCT4-expressing cells in the tumors, immunohistochemical analysis was performed on serial sections derived from the following tumors: osteosarcoma, glioblastoma and ductal carcinoma. figure 1The results shown indicate that OCT4-positive nuclei are present in osteosarcoma and glioblastoma; additionally, Image 6 The results shown in A-B indicate that OCT4-positive nuclei are also present in ductal carcinoma and breast cancer metastases to the brain, respectively. Although OCT4-positive cells were observed in both ductal carcinoma and breast cancer metastases, compared with primary breast cancer confined to ductal carcinoma ( Image 6 A), OCT4-positive nuclei appear more frequently in breast cancer metastases to the brain ( Image 6 B). Both tumors and metastases contain OCT4-positive cells, thus the methods described herein demonstrate that these OCT4-positive cells are eff...
Embodiment 2
[0140] OCT4, Nanog, and STAT3 are consistently expressed in glioblastoma clinical samples and cell lines
[0141] To determine whether OCT4, Nanog and STAT3 were co-expressed in glioblastoma clinical samples and in the cell lines LN18, LN229, LN428 and U251, semi-quantitative RT-PCR analysis followed by western blot analysis was performed. figure 2 A shows results showing moderate to high level mRNA expression of OCT4, Nanog and STAT3. The expression level of the protein is the same as that of figure 2 B shows the mRNA expression levels associated with, figure 2 Moderate to high protein expression levels of OCT4, Nanog and STAT3 are demonstrated in B.
Embodiment 3
[0143] OCT4 expression in stromal-attached or unattached growing tumor cells
[0144] To examine the effect of cell-matrix attachment on OCT4 expression in tumor cells, osteosarcoma and mammary tumor cells were grown as sarcospheres or mammospheres in matrix-attached or non-attached form, respectively. image 3 The results shown indicate that hi OCT4 and Nanog expression is dependent on cell attachment, thus tumor cells growing unattached in the form of sarcospheres and mammospheres express OCT4 and Nanog at high levels, in contrast to their inhibitory effects in stromal-attached tumor cells, in The expression of Nanog and OCT4 was relatively low in the latter case.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com